← Leaderboards
Emilio Sacristan
Nervive, Inc.
$1,575,676
Attributed
$3,151,351
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2017–21$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,151,351 · 1
By mechanism
U44$3,151,351 · 1
Top collaborators
- Stephanie Adi Harrington4 shared
Others in their field
Other Emerging Leaders on “Healthcare”
- Chanza Baytop · Westat, Inc.$200,838,189
- Abraham Aizer Brody · New York University School Of Medicine$47,356,047
- Susan M Landau · University Of California Berkeley$44,912,615
- Scott Topper · Broad Institute, Inc.$31,076,587
- Bryan Faller · Decatur Memorial Hospital$29,346,991
- Jennifer Marie Suga · Kaiser Foundation Research Institute$28,901,065
Research focus
HealthcareInstitutional Review BoardsAccident And Emergency DepartmentGrantHospitalsInjuryArteriesBrainDisabilityFreezingBlood CoagulationAlteplaseCathetersBlood FlowCerebral ArteryCerebrovascular CirculationClinical ResearchCoagulation ProcessAcuteDevicesEmergency TreatmentFacial Nerve StructureDevice DesignsIntravenous
Grant awards (4)
Early Feasibility Clinical Study of the VitalFlow Stimulator, an Emergency Treatment for Ischemic Stroke$940,888
U44 · FY2021 · NS · contact PI
Early Feasibility Clinical Study of the VitalFlow Stimulator, an Emergency Treatment for Ischemic Stroke$107,160
U44 · FY2020 · NS · contact PI
Early Feasibility Clinical Study of the VitalFlow Stimulator, an Emergency Treatment for Ischemic Stroke$1,486,705
U44 · FY2018 · NS · contact PI
Early Feasibility Clinical Study of the VitalFlow Stimulator, an Emergency Treatment for Ischemic Stroke$616,598
U44 · FY2017 · NS · contact PI